{"id":"https://openalex.org/W7225744084","doi":"https://doi.org/10.25251/v9tb4j58","title":"Improvements in Psoriasis, Including Sexual Function and Personal Relationships, With Roflumilast Cream 0.3% and Foam 0.3%: Outcomes From the Phase 3 DERMIS-1/2 and ARRECTOR Trials","display_name":"Improvements in Psoriasis, Including Sexual Function and Personal Relationships, With Roflumilast Cream 0.3% and Foam 0.3%: Outcomes From the Phase 3 DERMIS-1/2 and ARRECTOR Trials","publication_year":2026,"publication_date":"2026-11-10","ids":{"openalex":"https://openalex.org/W7225744084","doi":"https://doi.org/10.25251/v9tb4j58"},"language":"en","primary_location":{"id":"doi:10.25251/v9tb4j58","doi":"https://doi.org/10.25251/v9tb4j58","is_oa":true,"landing_page_url":"https://doi.org/10.25251/v9tb4j58","pdf_url":null,"source":{"id":"https://openalex.org/S4210210594","display_name":"SKIN The Journal of Cutaneous Medicine","issn_l":"2574-1624","issn":["2574-1624"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","poland-20"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SKIN The Journal of Cutaneous Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.25251/v9tb4j58","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044828308","display_name":"Michael J. Payette","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Payette","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031300337","display_name":"Tina Bhutani","orcid":"https://orcid.org/0000-0001-8187-1024","observed_orcids":["https://orcid.org/0000-0001-8187-1024"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tina Bhutani","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108214910","display_name":"Melodie S. Young","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Melodie Young","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033903141","display_name":"April Wang Armstrong","orcid":"https://orcid.org/0000-0003-0064-8707","observed_orcids":["https://orcid.org/0000-0003-0064-8707"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"April Armstrong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006526834","display_name":"Melinda Gooderham","orcid":"https://orcid.org/0000-0001-8926-0113","observed_orcids":["https://orcid.org/0000-0001-8926-0113"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Melinda J. Gooderham","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036685625","display_name":"Sandra Marchese Johnson","orcid":"https://orcid.org/0000-0001-8725-5767","observed_orcids":["https://orcid.org/0000-0001-8725-5767"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sandra M. Johnson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029113314","display_name":"Shehla Admani","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shehla Admani","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049624185","display_name":"Jeannette R. Jakus","orcid":"https://orcid.org/0009-0006-0137-9624","observed_orcids":["https://orcid.org/0009-0006-0137-9624"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeannette R. Jakus","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086310968","display_name":"Tiffany T. Mayo","orcid":"https://orcid.org/0000-0002-7015-3817","observed_orcids":["https://orcid.org/0000-0002-7015-3817"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tiffany Mayo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014417520","display_name":"John G. Zampella","orcid":"https://orcid.org/0000-0002-4886-4567","observed_orcids":["https://orcid.org/0000-0002-4886-4567"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Zampella","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030068079","display_name":"Tyler Lincoln","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tyler Lincoln","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069861834","display_name":"Melissa S. Seal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Melissa S. Seal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076208715","display_name":"Diane T. Hanna","orcid":"https://orcid.org/0000-0003-1162-9341","observed_orcids":["https://orcid.org/0000-0003-1162-9341"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Diane Hanna","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034746447","display_name":"Krista L. Bohnert","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Krista Bohnert","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5004761425","display_name":"Jennifer Clay Cather","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jennifer Cather","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"10","issue":"6","first_page":"s842","last_page":"s842"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7534000277519226},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.7440000176429749},{"id":"https://openalex.org/C2778926808","wikidata":"https://www.wikidata.org/wiki/Q693482","display_name":"Roflumilast","level":3,"score":0.6996999979019165},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.6057000160217285},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5102999806404114},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.47510001063346863},{"id":"https://openalex.org/C2777673923","wikidata":"https://www.wikidata.org/wiki/Q79928","display_name":"Acne","level":2,"score":0.4465999901294708},{"id":"https://openalex.org/C2776173921","wikidata":"https://www.wikidata.org/wiki/Q25326609","display_name":"Dermatology Life Quality Index","level":3,"score":0.4456999897956848},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4429999887943268},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.42829999327659607},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4088999927043915},{"id":"https://openalex.org/C2778515351","wikidata":"https://www.wikidata.org/wiki/Q9622","display_name":"Scalp","level":2,"score":0.4032000005245209},{"id":"https://openalex.org/C183021626","wikidata":"https://www.wikidata.org/wiki/Q4620674","display_name":"Sex organ","level":2,"score":0.37779998779296875},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.32580000162124634},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.32089999318122864},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.31459999084472656},{"id":"https://openalex.org/C2775871022","wikidata":"https://www.wikidata.org/wiki/Q7458776","display_name":"Sexual function","level":2,"score":0.296999990940094},{"id":"https://openalex.org/C2781427535","wikidata":"https://www.wikidata.org/wiki/Q2858961","display_name":"Apremilast","level":4,"score":0.296099990606308},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.2831999957561493},{"id":"https://openalex.org/C2910349174","wikidata":"https://www.wikidata.org/wiki/Q448310","display_name":"Seborrhoeic dermatitis","level":2,"score":0.2773999869823456},{"id":"https://openalex.org/C2777363609","wikidata":"https://www.wikidata.org/wiki/Q212328","display_name":"Sebaceous gland","level":2,"score":0.26649999618530273},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.265500009059906},{"id":"https://openalex.org/C2777011040","wikidata":"https://www.wikidata.org/wiki/Q390643","display_name":"Psoriasis Area and Severity Index","level":3,"score":0.2547999918460846},{"id":"https://openalex.org/C74534348","wikidata":"https://www.wikidata.org/wiki/Q410798","display_name":"cGMP-specific phosphodiesterase type 5","level":3,"score":0.25130000710487366}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.25251/v9tb4j58","doi":"https://doi.org/10.25251/v9tb4j58","is_oa":true,"landing_page_url":"https://doi.org/10.25251/v9tb4j58","pdf_url":null,"source":{"id":"https://openalex.org/S4210210594","display_name":"SKIN The Journal of Cutaneous Medicine","issn_l":"2574-1624","issn":["2574-1624"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","poland-20"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SKIN The Journal of Cutaneous Medicine","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.25251/v9tb4j58","doi":"https://doi.org/10.25251/v9tb4j58","is_oa":true,"landing_page_url":"https://doi.org/10.25251/v9tb4j58","pdf_url":null,"source":{"id":"https://openalex.org/S4210210594","display_name":"SKIN The Journal of Cutaneous Medicine","issn_l":"2574-1624","issn":["2574-1624"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","poland-20"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SKIN The Journal of Cutaneous Medicine","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":8,"referenced_works":["https://openalex.org/W4223997993","https://openalex.org/W4307249558","https://openalex.org/W4387719869","https://openalex.org/W4406212908","https://openalex.org/W4410353018","https://openalex.org/W7106053758","https://openalex.org/W7108229463","https://openalex.org/W7160943096"],"related_works":[],"abstract_inverted_index":{"Psoriasis":[0],"can":[1],"occur":[2],"on":[3,27,79,326],"any":[4],"body":[5,131,164],"area,":[6],"including":[7],"the":[8,66,106,125,152,160,327,350,420,448,471,489],"genitals.":[9],"Genital":[10],"involvement":[11,83,235,263,313,377,480],"impacts":[12],"quality":[13],"of":[14,20,81,124,140,155,159,205,323,353,423,429,435,440,463,491],"life,":[15],"particularly":[16],"intimacy/relationships.":[17],"Topical":[18],"treatment":[19,490],"genital":[21,82,234,262,312,376,479],"psoriasis":[22,64,123,209,331,465],"requires":[23],"special":[24],"considerations":[25],"based":[26,78],"thinner":[28],"skin":[29],"and":[30,36,56,70,75,117,130,151,163,198,229,244,257,307,363,371,386,415,425,454,460,466,474,485],"greater":[31],"absorption.":[32],"Roflumilast":[33,87,452],"cream":[34,88,453,484],"0.3%":[35,38,89],"foam":[37,91,455,487],"are":[39,84],"phosphodiesterase":[40],"4":[41],"inhibitor-based":[42],"advanced":[43],"targeted":[44],"topical":[45],"treatments":[46],"that":[47,329],"do":[48],"not":[49],"contain":[50],"potentially":[51],"irritating":[52],"excipients;":[53],"their":[54,330],"efficacy":[55],"safety":[57],"were":[58,95,157,186,396,410,456],"demonstrated":[59],"in":[60,65,102,105,230,258,283,308,349,372,378,400,419,470,475],"patients":[61,104,206,284,324,418,430,441],"with":[62,111,122,211,232,260,288,292,310,339,342,374,402,477],"plaque":[63,115,464],"phase":[67],"3":[68],"DERMIS-1/2":[69,107,141,354,379,424],"ARRECTOR":[71,118,156,364,387],"trials,":[72],"respectively.":[73,136,427],"Efficacy":[74],"quality-of-life":[76],"outcomes":[77],"presence":[80],"reported":[85,411,442],"here.":[86],"or":[90,93,175,404,444],"0.3%,":[92],"vehicle,":[94,359],"applied":[96],"once":[97],"daily":[98],"for":[99,215,245,398,412,488],"8":[100,150,348],"weeks":[101],"eligible":[103],"(aged":[108,119],"\u22652":[109],"years":[110,121,287],"at":[112,148,167],"least":[113,128,133],"mild":[114,445],"psoriasis)":[116],"\u226512":[120],"scalp":[126,161],"[at":[127,132],"moderate]":[129],"mild])":[134],"studies,":[135],"The":[137],"primary":[138],"endpoint":[139],"was":[142],"Investigator":[143],"Global":[144],"Assessment":[145],"(IGA)":[146],"success":[147,166,217,247],"week":[149,168,201,272,347],"co-primary":[153],"endpoints":[154],"IGA":[158],"(S-IGA)":[162],"(B-IGA)":[165],"8,":[169,202,273],"each":[170],"defined":[171],"as":[172],"clear":[173,177],"(0)":[174],"almost":[176],"(1)":[178],"plus":[179],"\u22652-point":[180],"improvement":[181],"from":[182,281,344],"baseline.":[183],"Additional":[184],"assessments":[185],"Worst":[187],"Itch-Numeric":[188],"Rating":[189],"Scale":[190],"(WI-NRS),":[191],"Dermatology":[192],"Life":[193],"Quality":[194],"Index":[195],"(DLQI),":[196],"safety,":[197],"tolerability.":[199],"At":[200,271],"higher":[203],"proportions":[204],"had":[207],"improved":[208,275,461],"signs/symptoms":[210,462],"roflumilast":[212,293,340,421,450,483,486],"versus":[213,294],"vehicle":[214,295,343],"IGA/B-IGA":[216],"overall":[218,248,296,351,472],"(DERMIS-1/2,":[219,297],"39.9%":[220],"vs":[221,225,237,240,250,253,265,269,299,303,315,319],"6.5%;":[222],"ARRECTOR,":[223,301,426],"45.5%":[224],"20.1%;":[226],"both":[227,242,255,305,457,482],"P<0.0001)":[228,256,306],"those":[231,259,309,373,476],"baseline":[233,261,282,289,311,345,375,478],"(39.3%":[236],"5.4%;":[238],"45.1%":[239],"5.7%;":[241],"P<0.005),":[243],"WI-NRS":[246],"(68.5%":[249],"31.3%;":[251],"63.1%":[252],"30.1%;":[254],"(71.0%":[264],"16.7%,":[266],"P<0.005;":[267],"63.6%":[268],"37.9%).":[270],"DLQI":[274,290,328],"(minimally":[276],"important":[277],"difference,":[278],"\u22654-point":[279],"reduction":[280],"aged":[285],"\u226517":[286],"\u22654)":[291],"73.3%":[298],"40.4%;":[300],"69.4%":[302],"36.2%;":[304],"(64.4%":[314],"34.6%,":[316],"P=0.0067;":[317],"81.8%":[318],"33.3%,":[320],"P<0.001).":[321],"Proportions":[322],"responding":[325],"caused":[332],"no/no":[333],"relevant":[334],"\u2018sexual":[335],"difficulties\u2019":[336],"increased":[337],"more":[338],"than":[341],"to":[346,357,361,366,369,381,384,389,392],"population":[352,473],"(roflumilast,":[355],"79.7%":[356],"92.1%;":[358],"77.0%":[360],"83.3%)":[362],"(80.4%":[365],"94.3%;":[367],"84.6%":[368],"89.4%)":[370],"(61.1%":[380],"84.2%;":[382],"81.6%":[383],"80.0%)":[385],"(52.2%":[388],"90.2%;":[390],"75.0%":[391],"78.3%).":[393],"Similar":[394],"trends":[395],"observed":[397],"improvements":[399],"\u2018problems":[401],"partners":[403],"relatives.":[405],"Application-site":[406],"pain":[407],"adverse":[408,437],"events":[409],"6":[413],"(1.0%)":[414],"1":[416],"(0.4%)":[417],"groups":[422],"\u22642.1%":[428],"discontinued":[431],"study":[432],"medication":[433],"because":[434],"an":[436],"event.":[438],"\u226595.0%":[439],"no":[443],"irritation":[446],"after":[447],"first":[449],"application.":[451],"well":[458],"tolerated":[459],"sexual":[467],"function/relationships.":[468],"Improvements":[469],"support":[481],"psoriasis.":[492]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-11T00:00:00"}